Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-123 manufacturers

Filters

Filters

Filters , active

Country of origin : China
1 products found

pp-123

Tablets

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Comments
Indication: Obesity (adults with BMI ≥30 kg/m² or ≥27 with comorbidity) Clinical stage: Phase 2 — ongoing in China Modality: Small molecule (oral GLP-1 receptor agonist) Mechanism / Target: GLP-1 receptor agonist — promotes insulin secretion, reduces appetite, slows gastric emptying Route / form: Oral tablet (once daily) Differentiation: Oral non-peptide GLP-1 agonist; potential dosing convenience advantage vs injectable semaglutide/liraglutide; wholly owned NCE
Manufacturer #39161

Clinical-stage biotechnology company focused on metabolic and infectious diseases. Develops novel oral small-molecule GLP-1 receptor agonists for obesity. Pursuing wholly owned global development strategy.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.